ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,224Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1448

$889K Total Retail Price of All Prescriptions

Rank: 38 out of 1448

475 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 13,023 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL SUCCINATE 849 837 1 6
SIMVASTATIN 744 742 2 3
ATORVASTATIN CALCIUM 609 599 3 4
AMLODIPINE BESYLATE 378 366 4 2
NEXIUM 333 302 5 49
OMEPRAZOLE 330 327 6 23
ZOLPIDEM TARTRATE 317 317 7 34
METFORMIN HCL 304 302 8 25
LIPITOR 283 283 9 30
DIGOXIN 230 230 10 13
ALENDRONATE SODIUM 226 224 11 41
WARFARIN SODIUM 224 224 12 8
FUROSEMIDE 213 213 13 7
AMLODIPINE BESYLATE-BENAZEPRIL 209 209 14 67
ATENOLOL 206 206 15 12
ESCITALOPRAM OXALATE 196 185 16 122
LANSOPRAZOLE 193 188 17 165
GABAPENTIN 190 174 18 51
PLAVIX 182 182 19 14
CRESTOR 181 179 20 17
SYNTHROID 178 166 21 90
ALLOPURINOL 175 172 22 43
DIOVAN 172 172 23 15
ADVAIR DISKUS 168 162 24 74
ZETIA 164 164 25 28
LOSARTAN-HYDROCHLOROTHIAZIDE 160 160 26 38
LEXAPRO 157 156 27 163
MELOXICAM 153 153 28 73
LEVOFLOXACIN 147 142 29 131
NIASPAN 140 140 30 47
CLOPIDOGREL 133 133 31 10
LOSARTAN POTASSIUM 133 133 31 11
LEVOTHYROXINE SODIUM 123 123 33 21
TAMSULOSIN HCL 115 115 34 46
LISINOPRIL 115 106 34 5
POTASSIUM CHLORIDE 103 103 36 19
CELEBREX 101 95 37 77
LOVAZA 100 100 38 39
VYTORIN 96 96 39 71
METOPROLOL TARTRATE 90 90 40 9
TRIAMTERENE-HCTZ 87 87 41 55
SERTRALINE HCL 83 79 42 99
DEXILANT 82 82 43 87
IBANDRONATE SODIUM 81 81 44 148
BONIVA 80 80 45 167
SINGULAIR 77 77 46 91
BENAZEPRIL HCL 77 77 46 26
PROPRANOLOL HCL 76 76 48 105
TRIAMCINOLONE ACETONIDE 74 74 49 96
HYDROCHLOROTHIAZIDE 73 72 50 18
NASONEX 71 71 51 155
LIDODERM 67 60 52 81
CARVEDILOL 67 60 52 1
PRAVASTATIN SODIUM 64 64 54 20
BENICAR HCT 62 62 55 84
PRADAXA 61 61 56 27
DIOVAN HCT 61 61 56 29
DOXAZOSIN MESYLATE 58 58 58 65
ISOSORBIDE MONONITRATE ER 57 57 59 16
PAROXETINE HCL 50 50 60 121
ACTOS 50 50 60 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.